Illumina (ILMN) Restructuring Costs (2012 - 2022)

Illumina (ILMN) posted Restructuring Costs of $609.0 million for Q3 2022, up 145943.17% quarter-over-quarter from $417000.0 in Q1 2017.

Illumina (ILMN) Restructuring Costs (2012 - 2022) Analysis & Trends

Illumina (ILMN) has reported Restructuring Costs for 6 consecutive years, with $609.0 million the latest figure, recorded in Q3 2022.

Restructuring Costs for Q3 2022 came in at $609.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jul 2022 was $609.8 million (up 55135.69% YoY), and the FY2017 annual result was $1.5 million, up 156.91% from the prior year.
Restructuring Costs was $609.0 million for Q3 2022 at Illumina, up from $417000.0 in the prior quarter.
Over five years, Restructuring Costs peaked at $609.0 million in Q3 2022 and troughed at $609.0 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Quest Diagnostics	23.76 Bn	23.67 Bn	942.00 Mn

Download Data